Comparison between Medicap Healthcare IPO and Turtlemint Fintech Solutions IPO.
Medicap Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Turtlemint Fintech Solutions IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Medicap Healthcare IPO is up to ₹240.00 Cr whereas the issue size of the Turtlemint Fintech Solutions IPO is up to ₹0.00 Cr. The final issue price of Medicap Healthcare IPO is and of Turtlemint Fintech Solutions IPO is .
| Medicap Healthcare IPO | Turtlemint Fintech Solutions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹240.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹240.00 Cr | up to ₹0.00 Cr |
Medicap Healthcare IPO opens on , while Turtlemint Fintech Solutions IPO opens on . The closing date of Medicap Healthcare IPO and Turtlemint Fintech Solutions IPO is , and , respectively.
Medicap Healthcare IPO P/E ratio is , as compared to Turtlemint Fintech Solutions IPO P/E ratio of .
| Medicap Healthcare IPO | Turtlemint Fintech Solutions IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Medicap Healthcare Ltd.'s revenue increased by 7% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98 | 17.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 27.30% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 17.67% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹-7.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 24.02% | -47.29% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Medicap Healthcare IPO Retail Individual Investors (RII) are offered 0 shares while in Turtlemint Fintech Solutions IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Medicap Healthcare IPO and 0 shares in Turtlemint Fintech Solutions IPO.
| Medicap Healthcare IPO | Turtlemint Fintech Solutions IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Medicap Healthcare IPO subscribed in total, whereas Turtlemint Fintech Solutions IPO subscribed .
